Rifamycin SV-MMX(®) for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria

BACKGROUND: The novel oral antibiotic formulation Rifamycin SV-MMX(®), with a targeted delivery to the distal small bowel and colon, was superior to placebo in treating travellers’ diarrhea (TD) in a previous study. Thus, a study was designed to compare this poorly absorbed antibiotic with the syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffen, Robert, Jiang, Zhi-Dong, Gracias Garcia, Mónica L, Araujo, Prithi, Stiess, Michael, Nacak, Tanju, Greinwald, Roland, DuPont, Herbert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331114/
https://www.ncbi.nlm.nih.gov/pubmed/30462260
http://dx.doi.org/10.1093/jtm/tay116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331114/
https://www.ncbi.nlm.nih.gov/pubmed/30462260
http://dx.doi.org/10.1093/jtm/tay116

Ejemplares similares